Crossref
The burgeoning liver disease at the interface of metabolic syndrome and type 2 diabetes: Nonalcoholic fatty liver disease (NAFLD)
Archives of Clinical Toxicology · 2024
DOI: 10.46439/toxicology.6.028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Clinical Toxicology, 2024. Verfasst von Shakil A Saghir und 3 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Saghir, S. A., Rohra, D. K., Almalki, R. S., & Ansari, R. (2024). The burgeoning liver disease at the interface of metabolic syndrome and type 2 diabetes: Nonalcoholic fatty liver disease (NAFLD). Archives of Clinical Toxicology. https://doi.org/10.46439/toxicology.6.028
Vancouver
Saghir SA, Rohra DK, Almalki RS, Ansari R. The burgeoning liver disease at the interface of metabolic syndrome and type 2 diabetes: Nonalcoholic fatty liver disease (NAFLD). Archives of Clinical Toxicology. 2024. doi:10.46439/toxicology.6.028
BibTeX
@article{Saghir2024,
author = {Saghir, Shakil A and Rohra, Dileep K and Almalki, Riyadh S. and Ansari, Rais},
title = {The burgeoning liver disease at the interface of metabolic syndrome and type 2 diabetes: Nonalcoholic fatty liver disease (NAFLD)},
journal = {Archives of Clinical Toxicology},
year = {2024},
doi = {10.46439/toxicology.6.028}
}
EUVIMED